Sivik Global Healthcare’s Amgen AMGN Stock Holding History

Sivik Global Healthcare’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,000	Closed	-$6.03M	–	41
2019 Q4	$6.03M	Buy	+25,000	New	+$5.51M	2.24%	21
2016 Q4	–	Sell	-45,000	Closed	-$7.51M	–	56
2016 Q3	$7.51M	Buy	45,000 +10,000	+29%	+$1.69M	3.78%	5
2016 Q2	$5.33M	Buy	35,000 +20,000	+133%	+$3.11M	2.65%	9
2016 Q1	$2.25M	Sell	15,000 -25,000	-63%	-$3.71M	1%	41
2015 Q4	$6.49M	Hold	40,000	–	–	3.08%	4
2015 Q3	$5.53M	Buy	+40,000	New	+$6.31M	2.68%	9
2015 Q2	–	Sell	-20,000	Closed	-$3.2M	–	73
2015 Q1	$3.2M	Sell	20,000 -19,700	-50%	-$3.1M	1.09%	41
2014 Q4	$6.32M	Buy	39,700 +9,700	+32%	+$1.51M	2.56%	10
2014 Q3	$4.21M	Buy	+30,000	New	+$3.92M	1.92%	17
2014 Q2	–	Sell	-25,000	Closed	-$3.08M	–	71
2014 Q1	$3.08M	Buy	+25,000	New	+$3.03M	1.93%	19

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sivik Global Healthcare's AMGN Position: Q1 2020 in Review

Sivik Global Healthcare sold out of Amgen (AMGN) in Q1 2020, closing a stake of 25,000 shares — an estimated $6.03M sold.

Sivik Global Healthcare first reported a position in AMGN in Q1 2014 and held it in 10 quarters. The position peaked at $7.51M in Q3 2016. 2,029 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

Sivik Global Healthcare reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
Sivik Global Healthcare sold 25,000 Amgen shares in Q1 2020, an estimated $6.03M.
Sivik Global Healthcare first reported a position in Amgen in Q1 2014 and held it in 10 quarters.
Sivik Global Healthcare's Amgen position peaked at $7.51M in Q3 2016.
2,029 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Sivik Global Healthcare's 13F filing for Q1 2020, filed 15 May 2020.